Connection

Susan Dorman to Cyclopropanes

Back to Details
This is a "connection" page, showing publications Susan Dorman has written about Cyclopropanes.
Susan Dorman
Connection Strength
0.053
Cyclopropanes
  1. Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine. Clin Infect Dis. 2022 09 10; 75(4):560-566.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.